These cells rely on the PINK1/Parkin pathway for mitophagy to sustain mitochondrial homeostasis
This is why dose increases are usually slow and step-by-step
Plus, the CFU count is guaranteed at the expiration date, as opposed to the manufacturing date
When the Breakthrough Obesity G-Agonist Drugs Exceed Expectations The expanding GLP-1 family of drugs and their expanded potential use cases Back last December I wrote about the The New Obesity Breakthrough Drugs, and specifically the striking results in randomized trials for semaglutide (Wegovy) and tirzepatide (Mounjaro) for weight loss, their putative mechanism(s), while also emphasizing their very high cost, lack of plan for successful weaning, and exacerbation of health inequities
The truth is, aging skin isnt just about time
Prevalence and awareness of melasma during pregnancy